The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
CancerStats. http://www.cancerresearchuk.org. 2005–2009.
Roxburgh, 2010, Role of systemic inflammatory response in predicting survival in patients with primary operable cancer, Future Oncology, 6, 149, 10.2217/fon.09.136
McMillan, 2012, The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer, Cancer Treatment Reviews
Gabay, 1999, Acute-phase proteins and other systemic responses to inflammation, New England Journal of Medicine, 340, 448, 10.1056/NEJM199902113400607
Zahorec, 2001, Ratio of neutrophil to lymphocyte counts – rapid and simple parameter of systemic inflammation and stress in critically ill, Bratislavske Lekarske Listy, 102, 5
Walsh, 2005, Neutrophil–lymphocyte ratio as a prognostic factor in colorectal cancer, Journal of Surgical Oncology, 91, 181, 10.1002/jso.20329
Schmidt, 2007, Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with american joint committee on cancer stage iv melanoma: results of the EORTC 18951 biochemotherapy trial, Journal of Clinical Oncology, 25, 1562, 10.1200/JCO.2006.09.0274
Clarke, 2011, Use of inflammatory markers to guide cancer treatment, Clinical Pharmacology and Therapeutics, 90, 475, 10.1038/clpt.2011.122
Proctor, 2011, A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study, European Journal of Cancer, 47, 2633, 10.1016/j.ejca.2011.03.028
Proctor, M.J. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow inflammation outcome study. Cancer, in press.
Motomura, 2013, Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment, Journal of Hepatology, 58, 58, 10.1016/j.jhep.2012.08.017
Kantola, 2012, Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma, British Journal of Cancer, 107, 1729, 10.1038/bjc.2012.456
Temel, 2010, Early palliative care for patients with metastatic non-small-cell lung cancer, New England Journal of Medicine, 363, 733, 10.1056/NEJMoa1000678
Azab, 2012, Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients, Annals of Surgical Oncology, 19, 217, 10.1245/s10434-011-1814-0
Proctor, 2012, A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer, British Journal of Cancer, 107, 695, 10.1038/bjc.2012.292
Ding, 2010, Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer, International Journal of Colorectal Disease, 25, 1427, 10.1007/s00384-010-1052-0
Kwon, 2012, Clinical significance of preoperative neutrophil–lymphocyte versus platelet–lymphocyte ratio in patients with operable colorectal cancer, Biomarkers, 17, 216, 10.3109/1354750X.2012.656705
Neal, 2011, Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases, Archives of Surgery, 146, 471, 10.1001/archsurg.2011.50
Leitch, 2007, Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer, British Journal of Cancer, 97, 1266, 10.1038/sj.bjc.6604027
Mallappa, 2012, Preoperative neutrophil lymphocyte ratio greater than five is a prognostic factor for recurrent colorectal cancer, Colorectal Disease, 323
Halazun, 2008, Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases, European Journal of Surgical Oncology, 34, 55, 10.1016/j.ejso.2007.02.014
Gomez, 2008, Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis, Journal of Surgical Oncology, 98, 371, 10.1002/jso.21103
Hung, 2011, Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy, International Journal of Colorectal Disease, 26, 1059, 10.1007/s00384-011-1192-x
Chiang, 2012, Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?, International Journal of Colorectal Disease, 1
Ubukata, 2010, Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients, Journal of Surgical Oncology, 102, 742, 10.1002/jso.21725
Aizawa, 2011, Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer, World Journal of Surgery, 35, 2717, 10.1007/s00268-011-1269-2
Jung, 2011, Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer, Journal of Surgical Oncology, 104, 504, 10.1002/jso.21986
Rashid, 2010, A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection, World Journal of Surgical Oncology, 8, 1, 10.1186/1477-7819-8-1
Wang, 2012, Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer, Tumor Biology, 33, 749, 10.1007/s13277-011-0285-z
Mohri, 2010, Prognostic significance of host- and tumor-related factors in patients with gastric cancer, World Journal of Surgery, 34, 285, 10.1007/s00268-009-0302-1
Shimada, 2010, High preoperative neutrophil–lymphocyte ratio predicts poor survival in patients with gastric cancer, Gastric Cancer, 13, 170, 10.1007/s10120-010-0554-3
Garcea, 2011, Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma, World Journal of Surgery, 35, 868, 10.1007/s00268-011-0984-z
Bhatti, 2010, Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil–lymphocyte versus platelet–lymphocyte ratio, American Journal of Surgery, 200, 197, 10.1016/j.amjsurg.2009.08.041
Smith, 2009, Preoperative platelet–lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma, American Journal of Surgery, 197, 466, 10.1016/j.amjsurg.2007.12.057
Wang, 2012, Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer, Tumour Biology, 33, 749, 10.1007/s13277-011-0285-z
Gomez, 2008, Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma, Journal of Surgical Oncology, 97, 513, 10.1002/jso.21001
Kinoshita, 2012, Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma, British Journal of Cancer, 107, 988, 10.1038/bjc.2012.354
Sakai, 2011, A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma, Annals of Thoracic and Cardiovascular Surgery, 17, 539, 10.5761/atcs.oa.11.01660
Sarraf, 2009, Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer, Journal of Thoracic and Cardiovascular Surgery, 137, 425, 10.1016/j.jtcvs.2008.05.046
Tomita, 2011, Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer, Anticancer Research, 31, 2995
Tomita, 2012, Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer, Anticancer Research, 32, 3535
Hashimoto, 2012, Clinical significance of preoperative peripheral blood neutrophil count in patients with non-metastatic upper urinary tract carcinoma, World Journal of Urology, 10.1016/j.juro.2012.02.714
Gondo, 2012, Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy, Urology, 79, 1085, 10.1016/j.urology.2011.11.070
Ohno, 2012, Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma, The World Journal of Urology, 10.1016/j.juro.2011.10.026
Ohno, 2012, Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma, The Journal of Urology, 187, 411, 10.1016/j.juro.2011.10.026
Cho, 2009, Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment, Cancer Immunology, Immunotherapy, 58, 15, 10.1007/s00262-008-0516-3
Idowu, 2012, Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma, Biomarkers, 17, 539, 10.3109/1354750X.2012.699554
Wang, 2011, A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation, PLoS One, 6, e25295, 10.1371/journal.pone.0025295
Halazun, 2009, Negative impact of neutrophil–lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma, Annals of Surgery, 250, 141, 10.1097/SLA.0b013e3181a77e59
Bertuzzo, 2011, Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers, Transplantation, 91, 1279, 10.1097/TP.0b013e3182187cf0
Sato, 2012, Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer, World Journal of Surgery, 36, 617, 10.1007/s00268-011-1411-1
Miyata, 2011, Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer, Experimental Therapeutics and Medicine, 2, 879, 10.3892/etm.2011.308
Sharaiha, 2011, Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer, Annals of Surgical Oncology, 18, 3362, 10.1245/s10434-011-1754-8
Carruthers, 2012, Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer, Colorectal Disease, 14, e701, 10.1111/j.1463-1318.2012.03147.x
Chua, 2012, Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy, Annals of Surgery, 256, 342, 10.1097/SLA.0b013e3182602ad2
Kishi, 2009, Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy, Annals of Surgical Oncology, 16, 614, 10.1245/s10434-008-0267-6
Cedres, 2012, Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer, Clinical and Translational Oncology, 14, 864, 10.1007/s12094-012-0872-5
Kao, 2010, High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy, Clinical Cancer Research, 16, 5805, 10.1158/1078-0432.CCR-10-2245
Yao, 2012, Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy, Cancer Immunology, Immunotherapy
Lee, 2012, Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy, Journal of Cancer Research and Clinical Oncology, 138, 2009, 10.1007/s00432-012-1281-4
Teramukai, 2009, Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03, European Journal of Cancer, 45, 1950, 10.1016/j.ejca.2009.01.023
Aliustaoglu, 2010, The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment, Medical Oncology, 27, 1060, 10.1007/s12032-009-9335-4
An, 2010, Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer, Biomarkers, 15, 516, 10.3109/1354750X.2010.491557
Keizman, 2012, The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma, European Journal of Cancer, 48, 202, 10.1016/j.ejca.2011.09.001
Chua, 2011, Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer, British Journal of Cancer, 104, 1288, 10.1038/bjc.2011.100
Kaneko, 2012, Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy, Oncology, 82, 261, 10.1159/000337228
McNally, 2013, Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization, Annals of Surgical Oncology, 20, 923, 10.1245/s10434-012-2639-1
Huang, 2011, Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization, Journal of Vascular and Interventional Radiology, 22, 702, 10.1016/j.jvir.2010.12.041
Jeong, 2012, Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer, Oncology, 83, 292, 10.1159/000342376